Zenas Bio rises as Wedbush launches with Outperform on lead asset
Shares of Zenas BioPharma (NASDAQ:ZBIO) rose on Thursday after Wedbush launched the newly IPO’ed biotech's coverage with an ...
Amgen outlook revised to positive by Fitch, ratings affirmed
Investing.com -- Fitch Ratings has revised its outlook for biopharmaceutical company Amgen Inc (NASDAQ: AMGN ). to positive ...